We describe an enhancement of our earlier computer program which allows calculation of decision thresholds, sensitivity and specificity, and likelihood ratios of negative and positive test results for any chosen value of sensitivity or specificity. The program will also plot continuous receiver operating characteristic and decision level curves which permit examination of the contours created by using all the available data. We illustrate the value of these routines by showing that the sensitivity and specificity of serum aspartate aminotransferase changes during the course of a myocardial infarction.
The selected decision threshold (cut-off) value of a laboratory test should provide the best diagnostic performance for either 'ruling-out' or 'rulingin' the particular disease. A diagnosis is ruled out if the test result is below the decision threshold determined by the selected diagnostic sensitivity' of the test, and is ruled in if the test result is above the decision threshold determined by the selected diagnostic specificity."
In conventional laboratory practice a simple reference interval is usual. However, the selected cut-off may be derived from the value which maximises the sum of the sensitivity and specificity of the test. I Other empirical methods include using a 2 x 2 table or tree model to select the cut-off point which gives the largest number of true positive and negative cases. ' We recently described a computer program which allowed us to plot the frequency distribution, receiver operating (or operator) characteristic (ROC) and decision level curves.? This latter curve provides an optimum decision value at the Correspondence: Dr F Y Leung.
• Diagnostic, or test, sensitivity (commonly referredto as 'sensitivity')is the true positive rate (fPR) of a test. b Diagnostic, or test, specificity (commonly referredto as 'specificity') is the true negative rate of a test. It can also be expressed as (l-FPR), where FPR is the false positiverate of a test. c Post-test odds= likelihood ratio. pre-test odds. maximum difference between the true and false positive rates. The program also has a singlepoint determination function which allows the calculation of sensitivity or specificity at chosen decision thresholds. However, the converse process, the selection of a decision threshold at chosen test sensitivities or specificities, is very tedious using this routine. In this paper we therefore present details of an enhancement to our previous ROC program which provides a more direct means of obtaining this data together with the generation of the likelihood ratios for both a positive and negative test result. Finally, the enhancement also allows the generation of continuous graphical plots of both ROC and decision level curves from all data points in the selected field.
Materials and methods

DESCRIPTION OF PROGRAM
The enhancement has been incorporated into our previously described program.' The program is written in standard MUMPS (MSM-PC, version 2.0E; Micronetics Design Corporation, Rockville, MD 20850, USA) for use in the MS-DOS environment (we use version 3,3) of a personal, IBM compatible, computer. We use a Roland (DXY-990) x-y plotter (Roland DG Corporation, Shizuoka-ken 432, Japan) for producing the continuous ROC curve and the MUMPS program contains instruction in Roland DG Graphic Language I (RD-GL I) which is compatible with Hewlett Packard HP-GL. Therefore, any plotter using HP-GL can be used with our program. Otherwise, plotting was by GraphPad (lSI Software, Institute for Scientific Information, Philadelphia, PA 19104, USA). While rough (screen or print) graphics are not possible with this enhancement, it is possible to produce such graphics using the original program. As before, the program permits the simultaneous assessment of up to nine sets of negative and positive populations. Each continuous ROC curve can therefore be superimposed on the same graph. The data can also be listed, in ascending test result order together with associated sensitivity, specificity, and likelihood ratios for negative and positive test results. Alternatively, the decision threshold for chosen sensitivities and specificities can be produced. The entire program runs in 640 K of RAM together with MS-DOS and MSM-PC. 
PA TlENT POPULATION
We illustrate the capabilities of this enhancement by the evaluation of serum aspartate aminotransferase (AST; EC 2.6.1.1) activities assayed at 4-6 h intervals up to 48 h after the onset of chest pain on 250 patients admitted to the Cardiac Care Unit of this hospital. Of these patients, 136 were subsequently confirmed as having had a myocardial infarction, while this diagnosis was excluded in 114 patients. Diagnoses were established by our previously described criteria: history of chest pain compatible with prolonged myocardial ischaemia, appropriate ECG changes, and noninvasive corroboration (2-D echo and/or scintigraphy).' . ",.
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Discussion
Werner et al. 6 showed that while lactate dehydrogenase (EC 1.1.1.27) and 2-hydroxybutyrate dehydrogenase (no EC number) provided diagnostic thresholds of constant sensitivity and specificity following a myocardial infarction this was not true for total creatine kinase (CK; EC 2.7.3.2.) or CK-2. Van Steirteghem et al, ' showed that to obtain a constant test sensitivity following a myocardial infarction the decision threshold had to be altered with time. We have confirmed routine. Alternatively, the program will print the entire data set tabulated in the same fashion. The data obtained from the type of tabulation displayed in Table 1 , for each of the 6 h windows, is shown plotted in Fig. 2. Figure 2(a) shows the decision thresholds, with respect to time from the onset of chest pain for three sensitivities, and Fig.  2(b) displays the decision thresholds for three specificities. Likewise, the likelihood ratios obtained from the same tabulations (Table 1) are shown plotted for a positive AST result (Fig. 3a) and for a negative AST result (Fig. 3b ). Figure 4 shows the continuous ROC curve at a selected time-period of 13-18 h compared to the discrete curve produced by the original program (see also Fig. 1 ). Figure 5 shows the continuous decision level curve at a selected time-period of 19-24 h compared to the discrete curve produced by the original program. elsewhere the findings ofVan Steirteghem et at. as regards both total CK, CK-2, and CK-2 expressed as a percentage of total CK following a myocardial infarction." The diagnostic efficacy of serum AST in myocardial infarction can be readily compared to other markers of myocardial tissue damage by use of the area under the curve (Fig. I) . At most time-intervals examined serum CK-2 is superior to serum total CK, which in turn is superior to serum AST. AST is marginally superior to total CK (respective areas under the curve are 0·930 and 0,912) at 43-48 h after the onset of chest pain. Thus, despite its continued use? serum AST is, in general, a less satisfactory marker for myocardial infarction than either total CK or CK-2. 8 The data analysed by the program illustrate the changes in decision threshold with time after infarction (Fig. 2) particularly for high sensitivities and specificities. Thus, to rule-out myocardial infarction when using a sensitivity of 95%, the decision thresholds are 14 and 38 U /L for the first 6 hand 19-24 h after the onset of chest pain, respectively. The magnitude of the difference is even greater at a higher sensitivity. Alternatively, to rule-in the diagnosis of myocardial infarction at a 95% level of specificity requires the same decision threshold for the first 24 h (about 50 U/L) but thereafter the decision threshold becomes 150 U /L during the 25-30 h period after the onset of chest pain. At a 90% specificity, the decision threshold is stable throughout the entire 48-h period; this should be contrasted with the rather erratic changes in the decision threshold to obtain results at the 99% level of specificity. These data convincingly demonstrate that the use of a constant decision threshold-usually the upper reference limit-is totally inadequate when applying, or attempting to apply, a constant diagnostic rule (i.e., a fixed sensitivity or specificity). This is yet another aspect of the quality of interpretative reporting." By contrast, specificities remain constant throughout the 48-h period following a myocardial infarction for both total CK and CK-2 although sensitivities vary as with AST.
The likelihood ratio for a positive test result increases from one during the first 6 h period to a maximum of between 8 and 12 between 19 and 36 h after infarction (Fig. 3a) . These ratios are the multipliers" for the pre-test (or prior) odds of disease presence and the product is the post-test (or posterior) odds of disease presence. Clearly therefore the higher the ratio, the more powerful the effect ofa positive test result on that particular diagnostic hypothesis. Conversely, the likelihood ratio for a negative test result (Fig. 3b ) will reduce the pre-test odds, and therefore the nearer that ratio approaches zero, the more powerful is the effect of a negative test result in excluding the suspected disease.
The likelihood ratio is a ratio of two probabilities'. Therefore, it can also be interpreted as follows. Ifan AST result of> 46 U/L is obtained 19-24 h after the onset of chest pain (see Table 1 ), such a finding is 10·7 times more likely in a patient with a myocardial infarction than in a patient without the infarction at a test sensitivity of90%.
Similarly, an AST result of < 46 U /L is a tenth as likely to occur in a patient with a myocardial infarction than in a patient without the infarction, when the test sensitivity is 90%.
The continuous ROC and decision level plots (Figs 4 and 5 ) allow a more detailed view of the data permitting a better selection of points on these curves than when using our original program. Presently, when we examine new data, we use the continuous plots before selecting the discrete data points for final graphing. This enhancement of our previous program is an extremely useful modification as it can be used to derive data in a form which can be immediately applied to the clinical diagnostic problem under investigation. We illustrate the value of these routines with a serum enzyme, AST, commonly used (although it probably should not be) for the diagnosis of myocardial infarction.
(Copies of the program may be obtained from FYL.)
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